Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

http://www.wikidata.org/entity/Q33666765

about

Importance of Apolipoprotein A-I in Multiple Sclerosis HDL and glucose metabolism: current evidence and therapeutic potential Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort.Cerebrospinal fluid markers of idiopathic intracranial hypertension: is the renin-angiotensinogen system involved?Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer's disease and other dementias.A role for hemopexin in oligodendrocyte differentiation and myelin formation.Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals.Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.Intravenously injected human apolipoprotein A-I rapidly enters the central nervous system via the choroid plexus.Anterior segment alterations and comparative aqueous humor proteomics in the buphthalmic rabbit (an American Ophthalmological Society thesis).Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathology.Co-immunoprecipitation with Tau Isoform-specific Antibodies Reveals Distinct Protein Interactions and Highlights a Putative Role for 2N Tau in Disease.Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations.Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.Genome-wide analysis of a Wnt1-regulated transcriptional network implicates neurodegenerative pathways.Role of progranulin as a biomarker for Alzheimer's disease.Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease.Use of proteomic methods in the analysis of human body fluids in Alzheimer research.Targeting heme oxygenase after intracerebral hemorrhage.A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression.Prion Protein Interactome: Identifying Novel Targets in Slowly and Rapidly Progressive Forms of Alzheimer's Disease.Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.Proteomics and metabolomics in ageing research: from biomarkers to systems biology.Evidence for a Role of Nerve Injury in Painful Intervertebral Disc Degeneration: A Cross-Sectional Proteomic Analysis of Human Cerebrospinal Fluid.Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.Amyloid-β sequester proteins as blood-based biomarkers of cognitive decline.Modifying effect of COMT gene polymorphism and a predictive role for proteomics analysis in children's intelligence in endemic fluorosis area in Tianjin, China.Cerebrospinal Fluid Proteins Identification Facilitates the Differential Diagnosis of Central Nervous System Diffuse Large B Cell Lymphoma.Impaired cortical oscillatory coupling in mild cognitive impairment: anatomical substrate and ApoE4 effects.Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.A simplified and sensitive method to identify Alzheimer's disease biomarker candidates using patient-derived induced pluripotent stem cells (iPSCs).3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis.Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer's disease - the case of florbetapir.Proteins linked to spatial memory formation of CD1 mice in the multiple T-maze.Pigment Epithelium-Derived Factor Plays a Role in Alzheimer's Disease by Negatively Regulating Aβ42.Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants.

P2860

Q26774792-F3A07EF0-F949-42AD-82D0-E91E291B0D4B Q26996502-2265F19D-B7E5-4D12-B27D-502BB8683C2F Q28259585-064ED574-33E7-4613-AC0F-A1F46F0980E5 Q33652456-200E4607-F07C-4E6E-9CCF-39C74198FF62 Q33727548-F640ADC2-5609-4AFC-A9BD-6DAE63D9A72A Q33821194-4ADC56C2-0AA8-4583-ABC6-9265B64C9580 Q33919796-223C4FB3-7993-4742-BBC3-49624C7D3278 Q34305083-B6256793-2DD6-4858-B8A3-8329301E2EFD Q34469280-9450FCD6-8DBA-426D-A02D-A79445AF8D64 Q35114943-075E69B4-398D-425D-BE99-279B7BDD597D Q35676399-F58F9E9A-35D5-4AC1-B033-E0638469B7DA Q35852564-838BE947-0C3D-4309-AFD4-A513A07AE53C Q35997824-9EDEB243-6BEC-4969-9F03-D62D80A91355 Q36121377-E7FEDFA6-9379-4B57-80B1-B46D12047EF9 Q36702235-26C01FFC-D920-4D49-8955-E512526DF8A3 Q36778845-4330BEE5-1C01-4D2A-B8F3-14C5E8D224EB Q36785476-CFC823BC-38CB-4785-BED9-486BAAF307B1 Q36925296-B0253D07-99D2-4FDD-8226-717A63742CA9 Q37377851-C722E605-FDDD-4BB1-81A6-2372152A7470 Q37730008-509D8116-CBB6-4CB6-96C9-B6ACABAD5B08 Q37987083-432B0D3F-6A3E-411D-9A0C-F8382510CD4C Q38060574-591944B9-AD93-47BF-8471-5DA6CD79975B Q38340631-EEFECF5A-D93C-4530-9A05-620EDC5E69AF Q38644393-E0A9B384-9B03-45D0-9688-6EA0609FCC0C Q38697135-A90B113C-3D26-4068-8218-623B7541D254 Q38833309-2FAD1B96-4FD6-4CA1-9489-282F1E002F79 Q39429374-E3339FE0-D059-46D2-80B9-3A0DDFA0C1B4 Q40144773-8BD346DB-76D4-48E6-9E01-40BE82797176 Q40401981-63563608-B4E2-405C-A69E-1EEBC3DF2114 Q42026180-1FA4ED54-82E7-4A8E-BD3D-3052B14B4630 Q42702996-6103A020-9912-4ED4-8931-36DA339E5808 Q43775146-D804D6F6-AA14-4978-ADEB-E54FD7AB3EEF Q44556621-4016862C-CB5A-483D-BC57-4AC5A31AFDBE Q47670919-85FB3E4D-001F-4943-B2CF-FFC4031A824B Q47677020-970EC021-95A2-4BE6-9D10-95A75778A357 Q50732857-BD9CFB46-AFF7-44E9-B6F4-4E2DF197CAF4 Q50981551-0749C2D2-6E56-4252-A3B5-2D01FB491CD0 Q51007041-D95FFDB3-FAD0-426A-8E2B-8889F65317FA Q53686278-9591F05B-D1E2-4D7D-9AFA-AC524B54A11D Q55266735-580395E9-C84F-4F4A-8A59-104EC8B13338

P2860

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

http://www.wikidata.org/entity/Q33666765

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

@ast

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

@en

type

label

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

@ast

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

@en

prefLabel

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

@ast

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

@en

P1433

Q33666765-74D1838A-7631-48ED-9044-722ADB9B0D11

P1476

Q33666765-A759706A-6F43-4700-B84D-00EC6326FA1F

P2093

Q33666765-38BB2366-3C46-4DDF-BB35-09C6766CAFB9

Q33666765-392D3C44-575A-493D-BD41-620CA33B8D47

Q33666765-80FD1F47-59ED-43D8-B863-EB7E2E87BD78

Q33666765-CCEF67DC-E204-4CD5-8D60-6AAA3326F912

Q33666765-CF7AE905-1E7F-4A60-A79A-B9462607B120

P2860

Q33666765-010082A6-B02B-40B6-A2EA-2DC48CD955C8

Q33666765-023FC42E-9F05-442C-930B-E7A4547E0AB8

Q33666765-084B075E-F821-41BC-ADEC-DE4A4F813C22

Q33666765-09FC1F1F-729D-4A04-B5B6-97FA731DC3A8

Q33666765-0E55B56A-30B1-4805-AD83-C0986D1F43D0

Q33666765-15889CAF-BE8F-46C0-B5A3-82F643433CBC

Q33666765-1617BB3D-DC4F-4A41-B50F-552111787CE6

Q33666765-1A9A0D87-6FC8-47A9-909D-14E1788EFB48

Q33666765-1B4C73B8-FAA4-4C96-8AD7-2A8F4DD9A275

Q33666765-25A1B72C-7115-455E-A9AC-53154896D933

P304

Q33666765-B2F8F1B0-839D-465E-A834-35C858018E5C

P31

Q33666765-0116DF76-6D50-46A1-AA54-E7C445E73124

P356

Q33666765-4E524394-6D7E-45CF-BC70-4DF20E637948

P433

Q33666765-6F0C92C2-0DA3-4350-BC11-9A860001F479

P478

Q33666765-9E400082-2A67-44C8-A598-807279A2F786

P50

Q33666765-EF4CD391-4FBF-4278-938A-143FA45AFBD3

P577

Q33666765-2DCE4BC6-72D6-4889-A956-5A74413B0CC6

P5875

Q33666765-4D54363C-1341-4305-B7A9-12425F94FCCA

P698

Q33666765-5B530BDC-B4F1-4B2E-B429-08A477198C15

P921

Q33666765-4BD7EB93-2A6C-42A3-86CC-C8D68D8A0F2B

Q33666765-6ECEA463-0877-4D19-ABD8-AD425AA9BCD2

Q33666765-E4F5F064-64F5-452A-B3E8-276DA3805509

P932

Q33666765-67D94B2E-04B0-45A9-8E1D-172C14D0C60F

P356

13547500903108423

P1433

P1476

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

@en

P2093

Alex E Roher

http://www.w3.org/2001/XMLSchema#string

Chera L Maarouf

http://www.w3.org/2001/XMLSchema#string

Jeffrey Wilson

http://www.w3.org/2001/XMLSchema#string

Lucia I Sue

http://www.w3.org/2001/XMLSchema#string

Yiran Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity

Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity

ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis

Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.

Cerebral amyloid angiopathy--a disease or age-related condition.

Identification of proteins in human cerebrospinal fluid using liquid-phase isoelectric focusing as a prefractionation step followed by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation mass spectrometry.

P304

493-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13547500903108423

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38042306

http://www.w3.org/2001/XMLSchema#string

P698

19863188

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

P932

2824250

http://www.w3.org/2001/XMLSchema#string